Drug Research
The Medicines Company introduces new Cleviprex formulation
The Medicines Company has launched a new twelve hour formulation for the FDA approved Cleviprex Injectable Emulsion.Cleviprex is an intravenous dihydropyridine calcium channel blocker, which...
Drug Research
Theraclone doses first patient in Phase 1 TCN-032 drug...
Theraclone Sciences has dosed first patient in a randomized, double-blind, dose-escalation Phase 1 trial investigating TCN-032 as a treatment for influenza A virus. ...
Drug Research
FDA approves Amphastar Enoxaparin Sodium Injection
The US Food and Drug Administration has approved Amphastar Pharmaceuticals' abbreviated new drug application for Enoxaparin Sodium Injection.The approval has been granted for 100mg/ml...
Drug Research
Dey Pharma to provide EpiPen Auto-Injectors
Mylan's subsidiary Dey Pharma is set to offer EpiPen 2-Pak and EpiPen Jr 2-Pak (epinephrine) Auto-Injector 0.3/0.15mg exclusively for the emergency treatment of severe allergic...
Drug Research
Unilife develops safety syringe to reconstitute lyophilized drugs
Unilife has developed Unifill EZMix multiple-chamber ready-to-fill (prefilled) safety syringe for lyophilized drugs and vaccines requiring reconstitution.Unifill EZMix syringes comprises two or more drug containers...
Drug Research
Allos recruits first patient in Phase 3 PTCL drug...
Allos Therapeutics has recruited first patient in a Phase 3 multi-center, randomized, open-label (PDX-017) Phase 2 trial investigating Folotyn (pralatrexate injection) in patients with previously...
Drug Research
Abbott two new strengths of CPP drug gets FDA...
Abbott has received the US Food and Drug Administration (FDA) approval for two new strengths of Lupron Depot-PED (leuprolide acetate for depot suspension) to treat...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.